Literature DB >> 11317069

Effect of highly active antiretroviral therapy on expression of interleukin-10 and interleukin-12 in HIV-infected patients.

Y Taoufik1, I Peguillet, M G de Goër, M Lambert, B Gubler, A Trylesinski, J F Delfraissy, O Lantz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11317069     DOI： 10.1097/00126334-200104010-00001

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  4 in total

1.  Low interleukin-10 production is associated with diabetes in HIV-infected patients undergoing antiviral therapy.

Authors:  Daria Trabattoni; Monica Schenal; Miriam Cesari; Eleonora Castelletti; Michela Pacei; Billi Goldberg; Andrea Gori; Mario Clerici
Journal:  Med Microbiol Immunol       Date:  2006-01-26       Impact factor: 3.402

2.  Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals.

Authors:  Susan Moir; Kisani M Ogwaro; Angela Malaspina; Joshua Vasquez; Eileen T Donoghue; Claire W Hallahan; Shuying Liu; Linda A Ehler; Marie A Planta; Shyamasundaran Kottilil; Tae-Wook Chun; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-01       Impact factor: 11.205

3.  Persistent HIV-1 replication does not explain low levels of T-cell interferon-gamma mRNA and elevated serum NO(2) (-)/NO(3) (-) in patients with stable CD4 T-cell responses to HAART.

Authors:  S Lee; C-A Almeida; M A H French; P Price
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

4.  Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.

Authors:  Susan Moir; Angela Malaspina; Oxana K Pickeral; Eileen T Donoghue; Joshua Vasquez; Natalie J Miller; Surekha R Krishnan; Marie A Planta; John F Turney; J Shawn Justement; Shyamasundaran Kottilil; Mark Dybul; JoAnn M Mican; Colin Kovacs; Tae-Wook Chun; Charles E Birse; Anthony S Fauci
Journal:  J Exp Med       Date:  2004-09-06       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.